Nathan Li

A court has tossed two cases centred on $5 million worth of pre-fabricated bathroom pods installed in two NSW developments, finding TQM and its related companies, which ordered the pods, did not owe supplier Buildom.

Software giant Oracle has won its bid to stay a $252 million fight with ATO over royalties, with the Full Federal Court finding the cases would not provide guidance in 15 other software disputes about the operation of the royalty tax. 

Builder Richard Crookes has won its costs after mediation was aborted in a case by the owners corporation for a building in Sydney’s Erskineville over aluminium composite panel cladding installed nine years ago. 

Builder Xela has failed in its bid to wind up the owner of a development to recoup a $776,000 debt owing under the Security of Payment Act, with a court finding that despite an unwillingness to pay, the owner is solvent. 

A class action against Fogo Brazilia and its law firm will be shut down if the lead franchisee fails to find $2.9 million in security for the restaurant chain's costs.

A class action against restaurant chain Fogo Brasilia and its law firm alleging franchisees were misled about the profitability of their businesses could be shut down, with the lead plaintiff unable to pay security for costs after the funder pulled out, a court has heard.

Mayfair 101’s James Mawhinney has defeated bankruptcy action by the owner of marketing firm 360 Degree Media, who claimed the founder of the beleaguered wealth management business owed him $3.5 million. 

A funder that was bankrolling a class action against restaurant chain Fogo Brazilia alleging it misled franchisees about the profitability of its businesses has “pulled the pin” on the case, with the law firm running the proceeding agreeing to act on a no win, no fee basis. 

The Australian unit of drug giant Mylan has triumphed in a dispute with Australian Taxation Office, with a judge finding the ATO's assessment for 2020 was "excessive" with respect to interest on loans to fund Mylan's $1.2 billion acquisition of generic drug maker Alphapharm.

Companies and government entities paid out less to settle class actions in 2023 than in the previous two years, with no mega settlements hitting their pocketbooks.